Search
Iovance Biotherapeutics Inc
IOVAAdd to Watchlist
4.070USD
-0.620-13.22%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.82BMarket Cap
LossP/E TTM
Iovance Biotherapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Iovance Biotherapeutics Inc is 7.46, ranking 171 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.41, which is -69.12% below the recent high of -1.36 and -109.84% above the recent low of -9.25.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.